Searching for Constitutive Androstane Receptor Modulators
1School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland paavo.honkakoski@uef.fi.
Abstract:
The constitutive androstane receptor (CAR; NR1I3) has been established as one of the main drug- and xenobiotic-responsive transcriptional regulators, collectively called xenosensors. CAR activates the expression of several oxidative, hydrolytic, and conjugative drug-metabolizing enzymes and drug transporters, and therefore, it contributes to drug and xenobiotic elimination, drug interactions, and toxicological processes. This minireview introduces mechanisms that modulate CAR activity and focuses on the recent approaches used to search and characterize CAR agonists, inverse agonists, and indirect activators. This minireview is dedicated to Dr. Masahiko Negishi to celebrate his scientific achievements during his long service at the National Institutes of Health. SIGNIFICANCE STATEMENT: Discovery and characterization of human constitutive androstane receptor (CAR) modulators is important for drug development, toxicity studies, and in generation of chemical tools to dissect biological functions of CAR. This minireview focuses on the main methods used to search for these compounds and discusses their essential features.
Insights
The constitutive androstane receptor (CAR) regulates drug metabolism and elimination. This review highlights methods for finding CAR modulators, crucial for drug development and toxicity studies.
Area of Science:
- Pharmacology
- Toxicology
- Molecular Biology
Background:
- The constitutive androstane receptor (CAR; NR1I3) is a key xenosensor regulating drug and xenobiotic metabolism.
- CAR influences the expression of drug-metabolizing enzymes and transporters, impacting drug interactions and toxicity.
- Understanding CAR's role is vital for drug development and assessing xenobiotic effects.
Purpose of the Study:
- To review mechanisms modulating CAR activity.
- To introduce recent approaches for identifying and characterizing CAR modulators (agonists, inverse agonists, indirect activators).
- To discuss the significance of CAR modulator discovery for drug development and biological research.
Main Methods:
- Literature review of mechanisms controlling CAR activity.
- Focus on recent screening and characterization methods for CAR agonists, inverse agonists, and indirect activators.
- Discussion of essential features of identified CAR modulators.
Main Results:
- CAR activation leads to increased expression of drug-metabolizing enzymes and transporters.
- Various methods exist for discovering and characterizing CAR modulators.
- CAR modulators are valuable tools for studying CAR's biological functions.
Conclusions:
- Discovery and characterization of CAR modulators are essential for advancing drug development and toxicology.
- Effective methods for identifying CAR modulators are crucial for dissecting CAR's biological roles.
- This review provides insights into current strategies for CAR modulator research.
More Related Videos
Related Concept Videos
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...


